NCT06636175
64Cu-LLP2A for Imaging Hematologic Malignancies No drug interventions diagnostic 0 not_yet_recruiting NCT00003499
Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma treatment 2 completed NCT00054808
Phase II Gallium Nitrate in Relapsed or Refractory Non-Hodgkin's Lymphoma treatment 2 completed NCT01300026
AMG 319 Lymphoid Malignancy FIH No drug interventions treatment 1 completed NCT00144092
HDCT and Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's Lymphoma No drug interventions treatment 2 completed NCT00791011
Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat treatment 1 completed NCT04773769
Study of Guanábana Leaves for The Treatment of Patients With Gastric, Gastroesophageal Junction, Pancreatic and Colorectal Adenocarcinomas; Hepatocellular Carcinoma, and Low Grade Lymphomas No drug interventions treatment Not Available unknown_status NCT00038883
Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies treatment Not Available terminated NCT00546793
Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL treatment 1 / 2 completed NCT01181271
Tandem Auto-Allo Transplant for Lymphoma treatment 2 completed NCT00036426
Idiotype Vaccine for Low-Grade Non-Hodgkin's Lymphoma treatment 2 unknown_status NCT00060684
Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma treatment 1 completed NCT00143884
Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood No drug interventions educational_counseling_training 2 terminated NCT00143845
Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant No drug interventions treatment 2 completed NCT00060671
Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's Lymphoma treatment 3 terminated NCT00220285
Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's Lymphoma treatment 2 completed NCT01263418
Ofatumumab In Older Patients With Untreated Low Or Intermediate Risk Indolent B-Cell Lymphomas treatment 2 withdrawn NCT00317096
FCM Versus R-FCM Followed by R-Maintenance or Observation Only treatment 3 unknown_status NCT00536458
Treatment of Localized Low Grade Lymphomas No drug interventions treatment 3 completed NCT00051025
Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL) treatment 2 completed NCT00168727
Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin's Lymphoma treatment 4 completed NCT00311129
Efficacy and Safety Study of SH T 586 in Combination With Rituximab to Treat Low-Grade NHL treatment 2 completed NCT03910283
Leveraging Mindsets to Improve Health & Wellbeing in Patients With Cancer No drug interventions supportive_care Not Available not_yet_recruiting